A pivotal scientific forum, under the distinguished moderation of the Financial Times and bearing the theme "How the Human Exposome Will Unlock Better Health and Medicine," is set to convene three leading figures from the Global Exposome Forum, representing both the United States and Europe. This distinguished gathering aims to provide the international research community with a comprehensive update on the significant strides made since the initiative’s inception in Washington D.C. in May of 2025. The session is specifically curated to introduce attendees of the American Association for the Advancement of Science (AAAS) to what is widely regarded as one of the most profound public health opportunities of our era: the comprehensive understanding of the human exposome. The deliberations will be structured around three principal pillars: the revolutionary potential inherent in exposomics research, the strategic blueprint for establishing a truly interconnected global network, and the pragmatic strategies necessary to surmount the scientific and policy-related hurdles that lie ahead.
Professor Thomas Hartung, a distinguished panel organizer from the Department of Environmental Health and Engineering at Johns Hopkins University Bloomberg School of Public Health, articulated the profound ambition underpinning this endeavor. He emphasized that their objective is to instigate substantial change, stating, "We are here to make waves, not ripples." He further elaborated on the intensive efforts of the Committee Members over the preceding nine months, noting the "tremendous surge in interest" that has culminated in concrete preparatory events and firm commitments. Professor Hartung indicated that a wealth of positive developments are on the horizon, and the panel discussion will feature three illustrative examples of significant buy-in from national governments, esteemed global scientific institutions, and large, membership-driven organizations. The event is scheduled to take place on Saturday, February 14th, 2026, from 10:00 AM to 11:00 AM MST in Room West 105 of the Phoenix Convention Center. This session is accessible to credentialed members of the press attending the AAAS Annual Meeting, and journalists and researchers with a keen interest in major public health initiatives and international grassroots collaboration are strongly encouraged to attend to gain direct insights from the pioneers of this rapidly evolving field.
The foundational concept of the Human Exposome Project is designed to rival, and potentially surpass, the transformative impact of the Human Genome Project. While the latter revolutionized our comprehension of genetics, it only addressed a partial component of the complex equation governing disease. Current estimates suggest that genetic predispositions account for a mere 10-20% of disease risk. In stark contrast, the cumulative effects of biological, chemical, and environmental exposures are believed to contribute to at least 80% of an individual’s susceptibility to illness. Despite the overwhelming significance of these external factors, large-scale, coordinated efforts to systematically study these exposures have been notably slow to materialize. However, this landscape is undergoing a significant transformation. Newly established regional chapters and specialized working groups are now actively escalating exposomics research through the integration of artificial intelligence, advanced sensor technologies, metabolomics, and sophisticated big data analytics. These collaborative teams are diligently forging partnerships with the express aim of translating scientific discoveries into actionable policies that benefit broad populations, rather than being confined to narrow demographic segments.
This ambitious initiative is being carefully aligned with existing global research endeavors, while simultaneously possessing the inherent capacity to expand in real-time and yield meaningful, tangible outcomes. The project’s architects acknowledge the critical importance of effectively integrating complex scientific guidance into the policymaking process, particularly concerning novel and sometimes contentious technologies, as an essential prerequisite for sustained success. The operational framework of the project is firmly rooted in a bottom-up model that actively engages both the general citizenry and elected officials. Proponents of this approach argue that whether the focus is on addressing the complexities of childhood autism and asthma, managing cognitive decline in aging populations, or establishing regulatory frameworks for microplastics, pesticides, and food colorants, research must prioritize a deep understanding of how the synergistic interplay of various exposures influences an individual’s health trajectory.
A significant development occurred on December 1st, 2025, in Pretoria, where the South African government utilized its Science Forum South Africa and the World Conference of Science Journalists, hosted by the Science Diplomacy Capital for Africa (SDCfA), as a platform to propel exposome collaboration forward. National and pan-African experts converged to meticulously assess the viability of establishing a continent-wide exposome network. Senior representatives from the Department of Science, Technology and Innovation (DSTI) were also privy to in-depth briefings. South Africa had previously demonstrated its commitment by participating at the Deputy Director-General level in the foundational Human Exposome Project launch event in Washington D.C. in May 2025. A direct and immediate consequence of the Pretoria gathering was the formal agreement for pan-African experts to engage directly with the working groups of the Global Exposome Forum and to actively participate in thematic meetings held internationally. A key initial priority identified was the enhancement of coordination within health data reporting systems. A subsequent workshop is slated for early December 2026, marking the one-year anniversary of the inaugural meeting. Concurrently, the SDCfA has formally indicated its willingness to serve as the inaugural host for a pan-African exposome network.
Professor Rémi Quirion, President of the International Network for Governmental Science Advice (INGSA), has emerged as a staunch advocate for exposomics and the expanding international consortium dedicated to its advancement. INGSA played a pivotal role in organizing a policy-oriented panel during the May 2025 meeting in Washington D.C., which featured distinguished speakers including chief scientists and leaders from organizations such as UNESCO, the World Health Organization (WHO), and the African Academy of Sciences. Since that time, INGSA has been instrumental in facilitating ongoing dialogue with the Global Exposome Forum regarding the effective integration of ‘exposomethics’ into the fabric of policymaking. Another high-level session is anticipated to take place on April 29th, 2026, during the Global Exposome Summit in Sitges, Spain. Furthermore, INGSA has committed to formalizing a collaborative partnership with the Global Exposome Forum, leveraging its extensive network of 10,000 members and numerous continental chapters to provide strategic guidance on engagement with science advisory systems on a global scale.
In another significant development on December 8th, 2025, the Global Exposome Forum formally launched a collaborative partnership with the Human Cell Atlas (HCA) and UNESCO. This groundbreaking alliance encompasses a series of focused virtual town hall meetings that will delve into critical areas such as single-cell analysis, genomics, exposomics, and science policy. UNESCO, which was represented at a senior level during the May 2025 Washington D.C. meeting, is expected to host a follow-up session in Paris on March 3rd, 2026, at the Assistant Director-General level. This forthcoming meeting is intended to lay the groundwork for the formal signing of a Memorandum of Understanding between UNESCO and the Global Exposome Forum.
The momentum behind this global endeavor continues to accelerate. Regional chapters are actively being established across Latin America and the Caribbean, as well as in Southeast Asia. Within Europe, the European Exposome Forum is spearheading the organization of the Global Exposome Summit, scheduled to convene in Sitges, Spain, from April 27th to 29th, 2026. Preliminary registration figures have already surpassed initial expectations, indicating a strong and widespread interest in the event, which promises to bring together leading authorities in health science, artificial intelligence, supercomputing, and forward-thinking policymaking.
A cornerstone of the Global Exposome Forum’s strategic framework lies in the establishment of specialized working groups dedicated to exposome research and its various sub-domains. These member-driven teams are tasked with the crucial responsibility of defining and addressing some of the field’s most pressing scientific and policy-related questions. Participants drawn from industry, governmental bodies, academic institutions, and civil society are actively collaborating through a dedicated digital platform, meticulously designed to facilitate seamless communication, secure document sharing, and the coordination of international initiatives. These working groups represent a fundamental element of the Global Exposome Forum’s organizational structure, embodying its grassroots, member-led ethos while simultaneously enabling large-scale coordination across diverse sectors and geographical boundaries.
Collectively, these multifaceted developments signify a decisive transition from the initial stages of planning to the robust phase of implementation. Through the strategic orchestration of public and private partnerships, the fostering of international cooperation, and the development of shared research infrastructure, the Global Exposome Forum is playing a crucial role in propelling exposomics from its status as an emerging concept to its realization as a genuinely transformative force in the realms of public health and modern medicine.
About the Author
